Chenyang Gu is currently an Analyst at Millennium, focusing on long/short equities in the pharma and biotech sectors since December 2022. Prior to this role, Chenyang worked at Goldman Sachs as part of the Biopharma Equity Research team, analyzing US large-cap pharma and biotech from June 2021 to November 2022. Earlier experience includes serving as a Health Economics and Outcomes Research Consultant at Analysis Group from September 2018 to May 2021. Chenyang's academic credentials include a Postdoctoral Fellowship at Harvard University, a Ph.D. in Biostatistics from Brown University, a Master’s degree in Statistics from Michigan State University, and a Bachelor’s degree in Statistics from Wuhan University of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices